Stock Taper 
RHENMAN & PARTNERS ASSET MANAGEMENT AB
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Abbott Laboratories | ABT | 96K | $8.71M |
 Biogen Inc. | BIIB | 94.85K | $20.49M |
 UnitedHealth Group Incorporated | UNH | 93.6K | $38.9M |
 BridgeBio Pharma, Inc. | BBIO | 91.1K | $6.79M |
 Bicara Therapeutics Inc. Common Stock | BCAX | 88.15K | $2.62M |
 Jazz Pharmaceuticals plc | JAZZ | 87.44K | $21.07M |
 Dianthus Therapeutics, Inc. | DNTH | 86.13K | $8.4M |
 Neurocrine Biosciences, Inc. | NBIX | 85.84K | $14.47M |
 Tenet Healthcare Corporation | THC | 85.2K | $15.94M |
 Alphatec Holdings, Inc. | ATEC | 85K | $735.25K |
 Danaher Corporation | DHR | 80.25K | $15.29M |
 Oruka Therapeutics, Inc. | ORKA | 80K | $7.61M |
 Doximity, Inc. | DOCS | 76.11K | $1.58M |
 Agilent Technologies, Inc. | A | 75K | $9.96M |
 Encompass Health Corporation | EHC | 74.26K | $7.51M |
 Johnson & Johnson | JNJ | 72.5K | $18.41M |
 Novocure Ltd | NVCR | 70K | $1.06M |
 Vericel Corporation | VCEL | 70K | $3.11M |
 Stryker Corporation | SYK | 65K | $20.46M |
 Stoke Therapeutics, Inc. | STOK | 64.5K | $2.11M |